» Authors » Xiao-He Xiao

Xiao-He Xiao

Explore the profile of Xiao-He Xiao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 261
Citations 1812
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiao X, Luo Y, Zhao X, Yang H, Yang Z, Zhang J, et al.
Zhongguo Zhong Yao Za Zhi . 2024 Dec; 49(19):5113-5124. PMID: 39701750
The evaluation of the effectiveness of traditional Chinese medicine(TCM) has long been a "bottleneck" issue that restricts the healthy development and internationalization of TCM. This article systematically analyzes the differences...
2.
Liu Y, Cheng C, Gao H, Zhu X, He X, Zhou M, et al.
Food Sci Nutr . 2024 Jul; 12(7):5100-5110. PMID: 39055233
Our previous clinical metabolomics study illustrated that energy metabolism disorder is an underlying pathogenesis mechanism for the development of alcoholic liver disease (ALD). Supplementation of nicotinamide (NAM), the precursor of...
3.
Li C, Xiao X, Li X, Xiao D, Wang Y, Wang X, et al.
Chin J Integr Med . 2024 Jun; 31(2):142-152. PMID: 38850483
Objective: To investigate the protective effects of stir-fried Semen Armeniacae Amarum (SAA) against aristolochic acid I (AAI)-induced nephrotoxicity and DNA adducts and elucidate the underlying mechanism involved for ensuring the...
4.
Xu Y, Wang X, Mu W, Wen J, Wang Y, Xiu Y, et al.
Zhongguo Zhong Yao Za Zhi . 2024 May; 49(10):2754-2765. PMID: 38812176
This study deciphered the ameliorating effect and molecular mechanism of the total glucosides of White Paeony Capsules(TGP) in the treatment of mice model with acute lung injury(ALI) via NOD-like receptor...
5.
Ge F, Yang Y, Si L, Li Y, Cao M, Wang J, et al.
World J Gastroenterol . 2024 Apr; 30(13):1911-1925. PMID: 38659485
Background: Liuweiwuling Tablet (LWWL) is a Chinese patent medicine approved for the treatment of chronic inflammation caused by hepatitis B virus (HBV) infection. Previous studies have indicated an anti-HBV effect...
6.
Lin M, Li Y, Cao B, Xu J, Xiao X, Li G, et al.
Zhongguo Zhong Yao Za Zhi . 2024 Feb; 49(2):443-452. PMID: 38403320
Chinese patent medicine preparations containing Epimedii Folium and Psoraleae Fructus have been associated with the occurrence of idiosyncratic drug-induced liver injury(IDILI). However, the specific toxic biomarkers and mechanisms underlying these...
7.
Su T, Fang Z, Guo Y, Wang C, Wang J, Ji D, et al.
Chin J Integr Med . 2023 Nov; 30(2):99-106. PMID: 37943487
Objective: To assess the risk of aristolochic acid (AA)-associated cancer in patients with AA nephropathy (AAN). Methods: A retrospective study was conducted on patients diagnosed with AAN at Peking University...
8.
Zhang M, Zhao X, Li W, Wang X, Niu M, Zhang H, et al.
Chin Med . 2023 Aug; 18(1):102. PMID: 37592331
Ethnopharmacological Relevance: Psoralea corylifolia Linn. (BGZ) is a commonly used traditional Chinese medicine (TCM) for the treatment of kidney-yang deficiency syndrome (Yang) with good curative effect and security. However, BGZ...
9.
Xiao X, Zhao X, Bai Z, Wang J, Song H
Zhongguo Zhong Yao Za Zhi . 2023 Jun; 48(10):2557-2564. PMID: 37282916
Profound changes have taken place in human disease spectrum, constitution spectrum, and drug use behavior, and the safety of traditional Chinese medicine(TCM) faces new trends and problems. In particular, serious...
10.
Jing J, Wang R, Bai Z, Guo Y, He T, Wang J, et al.
Zhongguo Zhong Yao Za Zhi . 2023 Jun; 48(9):2552-2556. PMID: 37282884
With the increase in the medical level, the improvement of adverse drug reaction(ADR) monitoring systems, and the enhancement of public awareness of safe medication, drug safety incidents have been frequently...